RepliCel Life Sciences Inc (OTCQB:REPCF.PK)

0.49
Data as of Aug 29
 -0.01 / -2.00%
Today’s Change
0.28
Today|||52-Week Range
0.87
-1.01%
Year-to-Date
SECTOR
Non-Energy Minerals
INDUSTRY
Precious Metals
MARKET CAP
$26.9M

Company Description

RepliCel Life Sciences, Inc. is engaged in the business of developing and patenting a new hair follicle cell replication technology. Its cellular replication and implantation technology is designed to grow new hair follicles in patients suffering from androgenetic alopecia. The procedure is also designed to rejuvenate damaged, miniaturized hair follicles in balding scalp skin. It was formerly known as Newcastle Resources Ltd. and changed its name to RepliCel Life Sciences, Inc. on June 22, 2011. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.

Contact Information

RepliCel Life Sciences, Inc.
401 West Georgia Street
Vancouver British Columbia V6B 5A1
P:(604) 248-8730
Investor Relations:
(604) 248-8696

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

David M. HallPresident, Chief Executive Officer & Director
Thomas Albert KordybackChief Financial Officer
Darrell PanichVice President-Clinical Affairs
Kevin McElweeChief Scientific Officer
Rolf HoffmannDirector & Chief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.